﻿<?xml version="1.0" encoding="utf-8"?>
<Return returnVersion="2012v2.0" xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2013-05-15T12:06:42-07:00</Timestamp>
    <TaxPeriodEndDate>2012-12-31</TaxPeriodEndDate>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2012-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>561683450</EIN>
      <Name>
        <BusinessNameLine1>CFIDS ASSOCIATION OF AMERICA INC</BusinessNameLine1>
      </Name>
      <NameControl>CFID</NameControl>
      <Phone>7043640016</Phone>
      <USAddress>
        <AddressLine1>6827 Fairview Road</AddressLine1>
        <AddressLine2>Suite A</AddressLine2>
        <City>Charlotte</City>
        <State>NC</State>
        <ZIPCode>28210</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>Kristina Hopkins</Name>
      <Title>Chief Financial Officer</Title>
      <Phone>7043640016</Phone>
      <DateSigned>2013-05-14</DateSigned>
    </Officer>
    <TaxYear>2012</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="9">
    <IRS990 documentId="R000001" referenceDocumentId="R000009" softwareId="12000197" softwareVersion="v1.00">
      <DoingBusinessAs>
        <BusinessNameLine1>CFIDS ASSOCIATION INC</BusinessNameLine1>
      </DoingBusinessAs>
      <NameOfPrincipalOfficerPerson>K Kimberly McCleary</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>6827 Fairview Road</AddressLine1>
        <AddressLine2>Suite A</AddressLine2>
        <City>Charlotte</City>
        <State>NC</State>
        <ZIPCode>28210</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>1104169</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>www.cfids.org</WebSite>
      <TypeOfOrganizationOther>X</TypeOfOrganizationOther>
      <TypeOfOrgOtherDescription>Non-Profit</TypeOfOrgOtherDescription>
      <YearFormation>1987</YearFormation>
      <StateLegalDomicile>NC</StateLegalDomicile>
      <ActivityOrMissionDescription>The Association's mission is for ME/CFS to be widely understood, diagnosable and treatable.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>10</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>10</NbrIndependentVotingMembers>
      <TotalNbrEmployees>8</TotalNbrEmployees>
      <TotalNbrVolunteers>22</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>1196911</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>1088346</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>20276</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>12357</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>1275</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>2615</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>1449</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>851</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>1219911</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>1104169</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>13003</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>235121</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>663916</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>578245</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>0</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>144667</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>442726</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>434770</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>1119645</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>1248136</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>100266</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>-143967</RevenuesLessExpensesCY>
      <TotalAssetsBOY>1133588</TotalAssetsBOY>
      <TotalAssetsEOY>1036291</TotalAssetsEOY>
      <TotalLiabilitiesBOY>53698</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>100368</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>1079890</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>935923</NetAssetsOrFundBalancesEOY>
      <MissionDescription>The mission of the CFIDS Association of America is for CFS to be widely understood, diagnosable and treatable by: Identifying safe and effective treatments for ME/CFS; Strengthening the ME/CFS community by empowering patients and engaging greater numbers in our cause; and Aggressively expanding funding for research that will lead to approved treatments and cures for ME/CFS.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>868414</Expense>
      <Grants>235121</Grants>
      <Revenue>12357</Revenue>
      <Description>Research - Building on investments in CFS research made by our organization and other agencies around the world, we broke new ground by announcing our latest research initiative in February 2012: the Research Institute Without Walls (RIWW). With the RIWW, the Association breaks out of the conventional non-profit role of simply sponsoring medical research and becomes a full partner with leading research institutions, putting patients at the core and center of tightly integrated projects that will advance objective diagnosis and effective treatment. The launch announcement included the funding of five new studies supported by Association grants totaling $460,440 along with three additional collaborations with CFS researchers; One important measure of impact is the amount of follow-on funding applied for and secured by Association-funded teams to foster larger studies. As of December 2012, 2009-2010 grantees attracted a combined total of $9 million in awards from the NIH, Department of Defense, pharmaceutical companies and foundations; In 2010 the Association established the SolveCFS BioBank as the first patient-centered registry and repository of clinical data and biological specimens for CFS. As of December 31, 525 participants were enrolled and the first proof-of-concept study with a major pharmaceutical partner was completed. The SolveCFS BioBank is at the hub of the Research Institute Without Walls and enables participants to take an active role in research. It has demonstrated value as a cost-effective resource for researchers who do not have access to clinical populations; In February 2012 Dr. Suzanne Vernon was invited to give a grand rounds presentation to Center for Drug Evaluation and Research (CDER) staff, helping deepen their understanding of CFS and the impact it has on individuals, families and our nation. The Association used this and other opportunities throughout the year to request that FDA convene a meeting to explore measures of treatment effectiveness or "endpoints" - the last one having been held in 1992. CDER staff hosted a teleconference with 50 participants (including Dr. Vernon and CEO Kim McCleary) in September. During that call, FDA affirmed that the agency considers ME/CFS to be a "serious and life-threatening condition, a formal designation that speeds decision-making processes and provides other incentives to researchers and industry who want to test therapies; In November, Suzanne Vernon, PhD and Biovista president Aris Persidis, PhD, were featured in one of the 30 "innovator" presentations at the Partnering for Cures conference in New York City, sponsored by FasterCures. The influential gathering gave us the opportunity to present to and meet personally with potential partners to advance promising drug repurposing candidates arising from our RIWW project with Biovista.</Description>
      <Activity2>
        <Expense>189854</Expense>
        <Grants>0</Grants>
        <Revenue>0</Revenue>
        <Description>Communications - In 2012, we strived to better convey the energizing and enterprising spirit with which the Association pursues its mission and to align our programs and information sources under a more cohesive "brand structure." We engaged expert communicators to help develop a new "look" for the Association, paired with fresh materials and clearer messages about the condition, the cause and the organization's work. Our intent is to invigorate the community of people we currently reach and to attract more people, resources and influence to the cause, translating to more treatment-focused research sooner; To meet the needs of the community we serve, the Association offered information and resources on CFS to patients, family members, media professionals, the general public and health care professionals throughout 2012. Relevant information on CFS-specific topics as well as general interest items were published in several locations: both Association websites (www.cfids.org and www.Research1st.org), Facebook page, monthly e-newsletters to 11,000 subscribers and a print publication "SolveCFS: the Chronicle of the CFIDS Association of America mailed to 5,600 contacts; The President &amp; CEO, Scientific Director and members of the Board of Directors participated in over 40 scientific conferences, meetings of federal agencies, media interviews and small group donor-related Catalyst Cafes, to share information about the CFIDS Association's innovative approach to research that is leading to effective treatment for ME/CFS; In late August, the Association teamed with two sets of partners to submit ideas for engaging patients in their health to Sanofi's Collaborate | Activate Innovation Challenge. One hundred proposals submitted by 280 collaborating nonprofits were reviewed by a team of five high-profile healthcare judges. On September 17 we learned that both our submissions had made it into the final round of four. Finalist status came with $25,000 and help from two mentors appointed by Sanofi for each team. One of our teams, Registries for All, won first prize with winnings being directed to our partner, Genetic Alliance, who will lead the implementation of the Registries for All project. Exposure through the competition to the world's fourth largest pharma company and other leaders in healthcare was valuable.</Description>
      </Activity2>
      <TotalOfOtherProgramServiceExp>0</TotalOfOtherProgramServiceExp>
      <TotalOfOtherProgramServiceGrnt>0</TotalOfOtherProgramServiceGrnt>
      <TotalOfOtherProgramServiceRev>0</TotalOfOtherProgramServiceRev>
      <TotalProgramServiceExpense>1058268</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="R000002">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="R000003">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <SubjectToProxyTax>0</SubjectToProxyTax>
      <DonorAdvisedFunds>0</DonorAdvisedFunds>
      <ConservationEasements>0</ConservationEasements>
      <CollectionsOfArt>0</CollectionsOfArt>
      <CreditCounseling>0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="R000004">1</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="R000004">1</ReportLandBldgEquip>
      <ReportInvestOthSecurities>0</ReportInvestOthSecurities>
      <ReportProgRelInvest>0</ReportProgRelInvest>
      <ReportOtherAssets>0</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="R000004">1</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="R000004">1</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="R000004">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="R000004">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities referenceDocumentId="R000005">1</ForeignActivities>
      <MoreThan5000KToOrganizations referenceDocumentId="R000005">1</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations referenceDocumentId="R000006">1</GrantsToOrganizations>
      <GrantsToIndividuals>0</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="R000007">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction>0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>0</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions referenceDocumentId="R000008">1</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity>0</DisregardedEntity>
      <RelatedEntity>0</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransfersToExemptNonChrtblOrg>0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership>0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>5</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>8</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>1</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>10</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>10</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>0</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>NC</StatesWhereCopyOfReturnIsFiled>
      <OwnWebsite>X</OwnWebsite>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NamePerson>Kristina P Hopkins</NamePerson>
        <TelephoneNumber>7043640016</TelephoneNumber>
        <AddressUS>
          <AddressLine1>6827 Fairview Road</AddressLine1>
          <AddressLine2>Suite A</AddressLine2>
          <City>Charlotte</City>
          <State>NC</State>
          <ZIPCode>28210</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>Diane R Bean</NamePerson>
        <Title>Secretary</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Victoria Boies PsyD</NamePerson>
        <Title>Vice Chairman</Title>
        <AverageHoursPerWeek>5</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Kevin Frick</NamePerson>
        <Title>Treasurer</Title>
        <AverageHoursPerWeek>5</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>K Kimberly McCleary</NamePerson>
        <Title>President &amp; CEO</Title>
        <AverageHoursPerWeek>40</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <KeyEmployee>X</KeyEmployee>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>160477</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>7128</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Bob Raidt</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Amy Squires</NamePerson>
        <Title>Chairman</Title>
        <AverageHoursPerWeek>8</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Patrick Venetucci</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Beth Garfield</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Adam Lesser</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Christine Williams</NamePerson>
        <Title>Director</Title>
        <AverageHoursPerWeek>1</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Suzanne P Vernon</NamePerson>
        <Title>Scientific Director</Title>
        <AverageHoursPerWeek>40</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>133163</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>5000</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>Kristina P Hopkins</NamePerson>
        <Title>Chief Financial Officer</Title>
        <AverageHoursPerWeek>40</AverageHoursPerWeek>
        <AverageHoursPerWeekRelated>0</AverageHoursPerWeekRelated>
        <HighestCompensatedEmployee>X</HighestCompensatedEmployee>
        <ReportableCompFromOrganization>77628</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>8500</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>371268</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>0</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>20628</TotalOtherCompensation>
      <NumberIndividualsGT100K>2</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <NumberOfContractorsGT100K>0</NumberOfContractorsGT100K>
      <FederatedCampaigns>21773</FederatedCampaigns>
      <MembershipDues>0</MembershipDues>
      <FundraisingEvents>0</FundraisingEvents>
      <RelatedOrganizations>0</RelatedOrganizations>
      <GovernmentGrants>0</GovernmentGrants>
      <AllOtherContributions>1066573</AllOtherContributions>
      <NoncashContributions>70437</NoncashContributions>
      <TotalContributions>1088346</TotalContributions>
      <ProgramServiceRevenue>
        <Description>Research subcontracts</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>12357</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>12357</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </ProgramServiceRevenue>
      <TotalOthProgramServiceRevenue>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </TotalOthProgramServiceRevenue>
      <TotalProgramServiceRevenue>12357</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>2615</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>2615</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </InvestmentIncome>
      <IncomeFromInvestBondProceeds>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </IncomeFromInvestBondProceeds>
      <RoyaltiesRevenue>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </RoyaltiesRevenue>
      <GrossRents>
        <Real>0</Real>
        <Personal>0</Personal>
      </GrossRents>
      <LessRentalExpenses>
        <Real>0</Real>
        <Personal>0</Personal>
      </LessRentalExpenses>
      <RentalIncomeOrLoss>
        <Real>0</Real>
        <Personal>0</Personal>
      </RentalIncomeOrLoss>
      <NetRentalIncomeOrLoss>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </NetRentalIncomeOrLoss>
      <GrossAmountSalesAssets>
        <Securities>0</Securities>
        <Other>0</Other>
      </GrossAmountSalesAssets>
      <LessCostOthBasisSalesExpenses>
        <Securities>0</Securities>
        <Other>0</Other>
      </LessCostOthBasisSalesExpenses>
      <GainOrLoss>
        <Securities>0</Securities>
        <Other>0</Other>
      </GainOrLoss>
      <NetGainOrLossInvestments>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </NetGainOrLossInvestments>
      <GrossIncomeFundraisingEvents>0</GrossIncomeFundraisingEvents>
      <CntrbtnsRprtdFundraisingEvents>0</CntrbtnsRprtdFundraisingEvents>
      <FundraisingDirectExpenses>0</FundraisingDirectExpenses>
      <NetIncomeFromFundraisingEvents>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </NetIncomeFromFundraisingEvents>
      <GrossIncomeGaming>0</GrossIncomeGaming>
      <GamingDirectExpenses>0</GamingDirectExpenses>
      <NetIncomeFromGaming>
        <TotalRevenueColumn>0</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </NetIncomeFromGaming>
      <GrossSalesOfInventory>851</GrossSalesOfInventory>
      <CostOfGoodsSold>0</CostOfGoodsSold>
      <NetIncomeOrLoss>
        <TotalRevenueColumn>851</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>851</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </NetIncomeOrLoss>
      <TotalOtherRevenue>0</TotalOtherRevenue>
      <TotalRevenue>
        <TotalRevenueColumn>1104169</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>15823</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>0</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>190246</Total>
        <ProgramServices>190246</ProgramServices>
      </GrantsToDomesticOrgs>
      <GrantsToDomesticIndividuals>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
      </GrantsToDomesticIndividuals>
      <ForeignGrants>
        <Total>44875</Total>
        <ProgramServices>44875</ProgramServices>
      </ForeignGrants>
      <BenefitsToMembers>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
      </BenefitsToMembers>
      <CompCurrentOfficersDirectors>
        <Total>160201</Total>
        <ProgramServices>132176</ProgramServices>
        <ManagementAndGeneral>11210</ManagementAndGeneral>
        <Fundraising>16815</Fundraising>
      </CompCurrentOfficersDirectors>
      <CompDisqualPersons>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </CompDisqualPersons>
      <OtherSalariesAndWages>
        <Total>367807</Total>
        <ProgramServices>326637</ProgramServices>
        <ManagementAndGeneral>14930</ManagementAndGeneral>
        <Fundraising>26240</Fundraising>
      </OtherSalariesAndWages>
      <PensionPlanContributions>
        <Total>8964</Total>
        <ProgramServices>6832</ProgramServices>
        <ManagementAndGeneral>1020</ManagementAndGeneral>
        <Fundraising>1112</Fundraising>
      </PensionPlanContributions>
      <OtherEmployeeBenefits>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>41273</Total>
        <ProgramServices>32724</ProgramServices>
        <ManagementAndGeneral>3255</ManagementAndGeneral>
        <Fundraising>5294</Fundraising>
      </PayrollTaxes>
      <FeesForServicesManagement>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </FeesForServicesManagement>
      <FeesForServicesLegal>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>19475</Total>
        <ProgramServices>15441</ProgramServices>
        <ManagementAndGeneral>1536</ManagementAndGeneral>
        <Fundraising>2498</Fundraising>
      </FeesForServicesAccounting>
      <FeesForServicesLobbying>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </FeesForServicesLobbying>
      <FeesForServicesProfFundraising>
        <Total>0</Total>
        <Fundraising>0</Fundraising>
      </FeesForServicesProfFundraising>
      <FeesForServicesInvstMgmntFees>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </FeesForServicesInvstMgmntFees>
      <FeesForServicesOther>
        <Total>129256</Total>
        <ProgramServices>83160</ProgramServices>
        <ManagementAndGeneral>1187</ManagementAndGeneral>
        <Fundraising>44909</Fundraising>
      </FeesForServicesOther>
      <Advertising>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </Advertising>
      <OfficeExpenses>
        <Total>11683</Total>
        <ProgramServices>9544</ProgramServices>
        <ManagementAndGeneral>701</ManagementAndGeneral>
        <Fundraising>1438</Fundraising>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>26892</Total>
        <ProgramServices>21236</ProgramServices>
        <ManagementAndGeneral>2154</ManagementAndGeneral>
        <Fundraising>3502</Fundraising>
      </InformationTechnology>
      <Royalties>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </Royalties>
      <Occupancy>
        <Total>65351</Total>
        <ProgramServices>51814</ProgramServices>
        <ManagementAndGeneral>5155</ManagementAndGeneral>
        <Fundraising>8382</Fundraising>
      </Occupancy>
      <Travel>
        <Total>74165</Total>
        <ProgramServices>60383</ProgramServices>
        <ManagementAndGeneral>645</ManagementAndGeneral>
        <Fundraising>13137</Fundraising>
      </Travel>
      <TravelEntrtnmntPublicOfficials>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TravelEntrtnmntPublicOfficials>
      <ConferencesMeetings>
        <Total>17679</Total>
        <ProgramServices>17039</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>640</Fundraising>
      </ConferencesMeetings>
      <Interest>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </Interest>
      <PaymentsToAffiliates>
        <Total>0</Total>
        <ProgramServices>0</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </PaymentsToAffiliates>
      <DepreciationDepletion>
        <Total>13192</Total>
        <ProgramServices>10459</ProgramServices>
        <ManagementAndGeneral>1041</ManagementAndGeneral>
        <Fundraising>1692</Fundraising>
      </DepreciationDepletion>
      <Insurance>
        <Total>7450</Total>
        <ProgramServices>5906</ProgramServices>
        <ManagementAndGeneral>588</ManagementAndGeneral>
        <Fundraising>956</Fundraising>
      </Insurance>
      <OtherExpenses>
        <Description>Miscellaneous</Description>
        <Total>23220</Total>
        <ProgramServices>16935</ProgramServices>
        <ManagementAndGeneral>1659</ManagementAndGeneral>
        <Fundraising>4626</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>SolveCFS BioBank</Description>
        <Total>24481</Total>
        <ProgramServices>24481</ProgramServices>
        <ManagementAndGeneral>0</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>Printing and Postage</Description>
        <Total>21926</Total>
        <ProgramServices>8380</ProgramServices>
        <ManagementAndGeneral>120</ManagementAndGeneral>
        <Fundraising>13426</Fundraising>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>1248136</Total>
        <ProgramServices>1058268</ProgramServices>
        <ManagementAndGeneral>45201</ManagementAndGeneral>
        <Fundraising>144667</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>1025010</BOY>
        <EOY>972541</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>45930</BOY>
        <EOY>11473</EOY>
      </PledgesAndGrantsReceivable>
      <AccountsReceivable>
        <BOY>1893</BOY>
        <EOY>937</EOY>
      </AccountsReceivable>
      <ReceivablesFromOfficersEtc>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </ReceivablesFromOfficersEtc>
      <ReceivablesFromDisqualPersons>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </ReceivablesFromDisqualPersons>
      <OtherNotesLoansReceivableNet>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </OtherNotesLoansReceivableNet>
      <InventoriesForSaleOrUse>
        <BOY>706</BOY>
        <EOY>515</EOY>
      </InventoriesForSaleOrUse>
      <PrepaidExpensesDeferredCharges>
        <BOY>8096</BOY>
        <EOY>8012</EOY>
      </PrepaidExpensesDeferredCharges>
      <LandBuildingsEquipmentBasis>176357</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>159390</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>26773</BOY>
        <EOY>16967</EOY>
      </LandBuildingsEquipmentBasisNet>
      <InvestmentsPubTradedSecurities>
        <BOY>0</BOY>
      </InvestmentsPubTradedSecurities>
      <InvestmentsOtherSecurities>
        <BOY>0</BOY>
      </InvestmentsOtherSecurities>
      <InvestmentsProgramRelated>
        <BOY>0</BOY>
      </InvestmentsProgramRelated>
      <IntangibleAssets>
        <BOY>0</BOY>
      </IntangibleAssets>
      <OtherAssetsTotal>
        <BOY>25180</BOY>
        <EOY>25846</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>1133588</BOY>
        <EOY>1036291</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>32340</BOY>
        <EOY>83112</EOY>
      </AccountsPayableAccruedExpenses>
      <GrantsPayable>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </GrantsPayable>
      <DeferredRevenue>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </DeferredRevenue>
      <TaxExemptBondLiabilities>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </TaxExemptBondLiabilities>
      <EscrowAccountLiability>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </EscrowAccountLiability>
      <LoansFromOfficersDirectors>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </LoansFromOfficersDirectors>
      <MortNotesPyblSecuredInvestProp>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </MortNotesPyblSecuredInvestProp>
      <UnsecuredNotesLoansPayable>
        <BOY>0</BOY>
        <EOY>0</EOY>
      </UnsecuredNotesLoansPayable>
      <OtherLiabilities>
        <BOY>21358</BOY>
        <EOY>17256</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>53698</BOY>
        <EOY>100368</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>997193</BOY>
        <EOY>806536</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <BOY>77297</BOY>
        <EOY>123987</EOY>
      </TemporarilyRestrictedNetAssets>
      <PermanentlyRestrictedNetAssets>
        <BOY>5400</BOY>
        <EOY>5400</EOY>
      </PermanentlyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>1079890</BOY>
        <EOY>935923</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>1133588</BOY>
        <EOY>1036291</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>-143967</ReconcilationRevenueExpenses>
      <ReconciliationUnrealizedInvest>0</ReconciliationUnrealizedInvest>
      <ReconcilationDonatedServices>0</ReconcilationDonatedServices>
      <ReconcilationInvestExpenses>0</ReconcilationInvestExpenses>
      <ReconcilationPriorAdjustment>0</ReconcilationPriorAdjustment>
      <ReconcilationOtherChanges>0</ReconcilationOtherChanges>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <FSAuditedBasis>
        <FinancialStatementSeparate>X</FinancialStatementSeparate>
      </FSAuditedBasis>
      <AuditCommittee>1</AuditCommittee>
      <FederalGrantAuditRequired>0</FederalGrantAuditRequired>
    </IRS990>
    <IRS990ScheduleA documentId="R000002" softwareId="12000197" softwareVersion="v1.00">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>1900404</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1150411</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>1244573</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1196911</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>1088346</CurrentTaxYear>
        <Total>6580645</Total>
      </GiftsGrantsContribReceived170>
      <TaxRevLeviedForOrgBenefit170>
        <Total>0</Total>
      </TaxRevLeviedForOrgBenefit170>
      <Total170>
        <CurrentTaxYearMinus4Years>1900404</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1150411</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>1244573</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1196911</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>1088346</CurrentTaxYear>
        <Total>6580645</Total>
      </Total170>
      <AmountsSubstContributorsTotal>374781</AmountsSubstContributorsTotal>
      <PublicSupportTotal170>6205864</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>10360</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5934</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>3053</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1275</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>2615</CurrentTaxYear>
        <Total>23237</Total>
      </GrossInvestmentIncome170>
      <OtherIncome170>
        <CurrentTaxYearMinus4Years>7338</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>5246</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2404</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1449</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>851</CurrentTaxYear>
        <Total>17288</Total>
      </OtherIncome170>
      <TotalSupport>6621170</TotalSupport>
      <GrossReceiptsFromAdmissionsEtc>12357</GrossReceiptsFromAdmissionsEtc>
      <PublicSupportPertcentage170>0.93728</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.99058</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
      <GeneralExplanation>Part II, Line 10 - Revenue was received from sale of educational materials</GeneralExplanation>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="R000003" softwareId="12000197" softwareVersion="v1.00">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="R000004" softwareId="12000197" softwareVersion="v1.00">
      <CurrentYear>
        <BeginningOfYearBalance>12031</BeginningOfYearBalance>
        <Contributions>0</Contributions>
        <InvestmentEarningsOrLosses>1478</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>0</GrantsOrScholarships>
        <OtherExpenditures>0</OtherExpenditures>
        <AdministrativeExpenses>163</AdministrativeExpenses>
        <EndOfYearBalance>13346</EndOfYearBalance>
      </CurrentYear>
      <CurrentYearMinus1Year>
        <BeginningOfYearBalance>12462</BeginningOfYearBalance>
        <Contributions>0</Contributions>
        <InvestmentEarningsOrLosses>-288</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>0</GrantsOrScholarships>
        <OtherExpenditures>0</OtherExpenditures>
        <AdministrativeExpenses>143</AdministrativeExpenses>
        <EndOfYearBalance>12031</EndOfYearBalance>
      </CurrentYearMinus1Year>
      <CurrentYearMinus2Years>
        <BeginningOfYearBalance>11087</BeginningOfYearBalance>
        <Contributions>0</Contributions>
        <InvestmentEarningsOrLosses>1505</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>0</GrantsOrScholarships>
        <OtherExpenditures>0</OtherExpenditures>
        <AdministrativeExpenses>130</AdministrativeExpenses>
        <EndOfYearBalance>12462</EndOfYearBalance>
      </CurrentYearMinus2Years>
      <CurrentYearMinus3Years>
        <BeginningOfYearBalance>9518</BeginningOfYearBalance>
        <Contributions>0</Contributions>
        <InvestmentEarningsOrLosses>2145</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>0</GrantsOrScholarships>
        <OtherExpenditures>464</OtherExpenditures>
        <AdministrativeExpenses>112</AdministrativeExpenses>
        <EndOfYearBalance>11087</EndOfYearBalance>
      </CurrentYearMinus3Years>
      <CurrentYearMinus4Years>
        <BeginningOfYearBalance>13193</BeginningOfYearBalance>
        <Contributions>0</Contributions>
        <InvestmentEarningsOrLosses>-3531</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>0</GrantsOrScholarships>
        <OtherExpenditures>0</OtherExpenditures>
        <AdministrativeExpenses>144</AdministrativeExpenses>
        <EndOfYearBalance>9518</EndOfYearBalance>
      </CurrentYearMinus4Years>
      <BoardDesignatedEOYBalance>0.6</BoardDesignatedEOYBalance>
      <PermanentEndowmentEOYBalance>0.4</PermanentEndowmentEOYBalance>
      <TermEndowmentEOYBalance>0</TermEndowmentEOYBalance>
      <EndowmentsHeldByUnrelatedOrgs>0</EndowmentsHeldByUnrelatedOrgs>
      <EndowmentsHeldByRelatedOrgs>0</EndowmentsHeldByRelatedOrgs>
      <Land>
        <InvestmentCostOrOtherBasis>0</InvestmentCostOrOtherBasis>
        <OtherCostOrOtherBasis>0</OtherCostOrOtherBasis>
        <BookValue>0</BookValue>
      </Land>
      <Buildings>
        <InvestmentCostOrOtherBasis>0</InvestmentCostOrOtherBasis>
        <OtherCostOrOtherBasis>0</OtherCostOrOtherBasis>
        <Depreciation>0</Depreciation>
        <BookValue>0</BookValue>
      </Buildings>
      <LeaseholdImprovements>
        <InvestmentCostOrOtherBasis>0</InvestmentCostOrOtherBasis>
        <OtherCostOrOtherBasis>29259</OtherCostOrOtherBasis>
        <Depreciation>26550</Depreciation>
        <BookValue>2709</BookValue>
      </LeaseholdImprovements>
      <Equipment>
        <InvestmentCostOrOtherBasis>0</InvestmentCostOrOtherBasis>
        <OtherCostOrOtherBasis>147098</OtherCostOrOtherBasis>
        <Depreciation>132840</Depreciation>
        <BookValue>14258</BookValue>
      </Equipment>
      <OtherLandBuildings>
        <InvestmentCostOrOtherBasis>0</InvestmentCostOrOtherBasis>
        <OtherCostOrOtherBasis>0</OtherCostOrOtherBasis>
        <Depreciation>0</Depreciation>
        <BookValue>0</BookValue>
      </OtherLandBuildings>
      <TotalOfBookValueLandBuildings>16967</TotalOfBookValueLandBuildings>
      <FederalIncomeTaxLiability>0</FederalIncomeTaxLiability>
      <OtherLiabilities>
        <Description>Obligation under capital lease less current</Description>
        <Amount>17256</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>17256</TotalOfAmounts>
      <FootnoteInPartXIII>X</FootnoteInPartXIII>
      <TotRevenueEtcAuditedFinclStmt>1104169</TotRevenueEtcAuditedFinclStmt>
      <NetUnrealizedGainsInvestments>0</NetUnrealizedGainsInvestments>
      <DonatedSrvcAndUseOfFacilities>0</DonatedSrvcAndUseOfFacilities>
      <RecoveriesOfPriorYearGrants>0</RecoveriesOfPriorYearGrants>
      <OtherRevenues>0</OtherRevenues>
      <RevenueNotRptdF990>0</RevenueNotRptdF990>
      <RevenueSubtotal>1104169</RevenueSubtotal>
      <InvestmentExpensesNotIncluded>0</InvestmentExpensesNotIncluded>
      <OtherRevenuesNotIncluded>0</OtherRevenuesNotIncluded>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>1104169</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>1248136</TotExpensesEtcAuditedFinclStmt>
      <DonatedServicesUseOfFacilities>0</DonatedServicesUseOfFacilities>
      <PriorYearAdjustments>0</PriorYearAdjustments>
      <LossesReported>0</LossesReported>
      <OtherExpensesIncluded>0</OtherExpensesIncluded>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>1248136</ExpensesSubtotal>
      <InvestmentExpensesNotIncluded2>0</InvestmentExpensesNotIncluded2>
      <OtherExpensesNotIncluded>0</OtherExpensesNotIncluded>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>1248136</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIII>
        <Identifier>SchD_P05_S00_L04</Identifier>
        <ReturnReference>Schedule D, Part V, Line 4</ReturnReference>
        <Explanation>Schedule D, Part V, Line 4 - The CFIDS Association of America's Endowment Fund is held at the Foundation for the Carolinas. It is a permanent fund created to ensure the future stability of the Association. The principal of the endowment is never touched, however income generated can be used to support Association programs, if needed. Spendable income has historically been reinvested in the Endowment Fund to increase its balance.</Explanation>
      </Form990ScheduleDPartXIII>
      <Form990ScheduleDPartXIII>
        <Identifier>SchD_P10_S00_L02</Identifier>
        <ReturnReference>Schedule D, Part X, Line 2</ReturnReference>
        <Explanation>Schedule D, Part X, Line 2 - The Association is a nonprofit voluntary health agency under the laws of the State of North Carolina. Further, the Association is exempt from federal income tax as an organization described in Section 501(c)(3) of the Internal Revenue Code (the "Code") and qualifies as a public charity under Code Sections 509(a)(1) and 107(b)(1)(A)(vi). The Association follows the Financial Accounting Standards Board ("FASB") guidance on accounting for uncertainty in income taxes. The Association's policy is to record a liability for any tax position taken that is beneficial to the Association, including any related interest and penalties, when it is more likely than not the position taken by management with respect to a transaction or class of transactions will be overturned by a taxing authority upon examination. Management believes there are no such positions as of December 31, 2012 and, accordingly, no liability has been accrued. Income tax returns filed prior to the year ended December 31, 2009, are no longer subject to audit by the taxing authority.</Explanation>
      </Form990ScheduleDPartXIII>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="R000005" softwareId="12000197" softwareVersion="v1.00">
      <GrantRecordsMaintained>1</GrantRecordsMaintained>
      <AcctsActvsOutUSTable>
        <Region>North America (including Canada and Mexico, but not the United States)</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>Grantmaking</TypeOfActivitiesConducted>
        <SpecificServicesProvided>Patrick McGowan, Ph.D., of the University of Toronto Scarborough will build on evidence of environmental influences that affect the function of the immune system in CFS patients. Using samples collected through the SolveCFS BioBank, McGowan will look for genome-wide epigenetic changes and assess whether these alter the immune response. This study may uncover novel diagnostic and therapeutic biomarkers.</SpecificServicesProvided>
        <TotalExpenditures>44875</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <TotalNumberOfOffices>0</TotalNumberOfOffices>
      <TotalNumberOfEmployees>0</TotalNumberOfEmployees>
      <TotalAmountSpent>44875</TotalAmountSpent>
      <GrantsToOrgsOutsideUS>
        <Region>North America (including Canada and Mexico, but not the United States)</Region>
        <PurposeOfGrant>Patrick McGowan, Ph.D., of the University of Toronto Scarborough will build on evidence of environmental influences that affect the function of the immune system in CFS patients. Using samples collected through the SolveCFS BioBank, McGowan will look for genome-wide epigenetic changes and assess whether these alter the immune response. This study may uncover novel diagnostic and therapeutic biomarkers.</PurposeOfGrant>
        <AmountOfCashGrant>44875</AmountOfCashGrant>
        <MannerOfCashDisbursement>Check</MannerOfCashDisbursement>
        <AmountOfNonCashAssistance>0</AmountOfNonCashAssistance>
      </GrantsToOrgsOutsideUS>
      <TotalNumberOf501c3Orgs>1</TotalNumberOf501c3Orgs>
      <TotalNumberOfOtherOrgs>0</TotalNumberOfOtherOrgs>
      <TransferToForeignCorp>0</TransferToForeignCorp>
      <InterestInForeignTrust>0</InterestInForeignTrust>
      <OwnForeignCorp>0</OwnForeignCorp>
      <PassiveForeignInvestCo>0</PassiveForeignInvestCo>
      <ForeignPartnership>0</ForeignPartnership>
      <BoycottCountries>0</BoycottCountries>
      <Form990ScheduleFPartV>
        <Identifier>SchF_P01_S00_L02</Identifier>
        <ReturnReference>Schedule F, Part I, Line 2</ReturnReference>
        <Explanation>Schedule F, Part I, Line 2 - The Association awards grants for medical research projects in the field of CFS. To ensure that the most worthy and promising research projects are funded, the Association periodically engages volunteer peer reviewers with direct experience in the disciplines and fields specific to each funding application. Their reviews for scientific and strategic merit are weighed heavily by the Executive Committee of the Board of Directors when making final funding decisions. Applicants and their sponsoring organizations must agree and adhere to the Policies Governing the Award of Research Grants when completing the application form. Grantees approved for funding are required to submit written quarterly reports of the study's progress to the Association's Scientific Director according to the schedule outlined in the final letter of award. Grantee organizations are also required to submit two interim financial reports - at 7-month and 12-month intervals - to the Association's Chief Financial Officer. Failure to submit required reports by stated deadlines will result in suspension of future quarterly grant disbursements until all outstanding reports are received. Repeated or prolonged delinquency in reporting may result in suspension or withdrawal of support. The Association's Scientific Director may request a site visit or conference call to discuss information contained in interim progress reports and general progress toward stated project milestones. A Scientific Advisory Board comprised of researchers, physicians and regulatory experts provides guidance on the Association's research strategy to the staff and Board of Directors. It convenes periodically throughout the year.</Explanation>
      </Form990ScheduleFPartV>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="R000006" softwareId="12000197" softwareVersion="v1.00">
      <RecordsMaintained>1</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>Biovista</BusinessNameLine1>
          <BusinessNameLine2>Spyros Deftereos MD PhD</BusinessNameLine2>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>2421 Ivy Road</AddressLine1>
          <City>Charlottesville</City>
          <State>VA</State>
          <ZIPCode>22903</ZIPCode>
        </AddressUS>
        <EINOfRecipient>870744294</EINOfRecipient>
        <AmountOfCashGrant>100000</AmountOfCashGrant>
        <AmountOfNonCashAssistance>0</AmountOfNonCashAssistance>
        <PurposeOfGrant>Biovista will use a proprietary, very large-scale drug repurposing platform called the Clinical Outcome Search Space (COSS) to analyze the biomedical literature, patents, adverse event databases and other information sources to systematically identify non-obvious new drug candidates to treat CFS.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>University of Wisconsin - Madison</BusinessNameLine1>
          <BusinessNameLine2>Dane Cook PhD</BusinessNameLine2>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>2000 Observatory Drive</AddressLine1>
          <AddressLine2>Gymnatorium Natatorium</AddressLine2>
          <City>Madison</City>
          <State>WI</State>
          <ZIPCode>53706</ZIPCode>
        </AddressUS>
        <EINOfRecipient>396006492</EINOfRecipient>
        <IRCSection>501(c)(3)</IRCSection>
        <AmountOfCashGrant>33333</AmountOfCashGrant>
        <AmountOfNonCashAssistance>0</AmountOfNonCashAssistance>
        <PurposeOfGrant>Dane Cook, Ph.D., of the University of Wisconsin-Madison has teamed with Alan Light of the University of Utah and Gordon Broderick of the University of Alberta to link information gathered from exercise testing, brain imaging and gene expression markers in the blood to understand post-exertional relapse, a hallmark feature of CFS. This project will attempt to validate blood and brain markers independently identified by these investigators in earlier studies.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>New York Medical College</BusinessNameLine1>
          <BusinessNameLine2>Marvin Medow PhD</BusinessNameLine2>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>The Center for Hypotension</AddressLine1>
          <AddressLine2>19 Bradhurst Ave Suite 1600 South</AddressLine2>
          <City>Hawthorne</City>
          <State>NY</State>
          <ZIPCode>10532</ZIPCode>
        </AddressUS>
        <EINOfRecipient>113109942</EINOfRecipient>
        <IRCSection>501(c)(3)</IRCSection>
        <AmountOfCashGrant>33333</AmountOfCashGrant>
        <AmountOfNonCashAssistance>0</AmountOfNonCashAssistance>
        <PurposeOfGrant>Marvin S. Medow, Ph.D., New York Medical College in Valhalla, N.Y., will extend earlier work supported by the Association that shows orthostatic challenge, such as prolonged upright posture, leads to problems with memory, concentration and information processing in CFS patients. After measuring brain blood flow during a head upright tilt test while testing cognitive ability, he will test three interventions to identify mechanisms to improve neurocognitive impairment.</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>The Johns Hopkins University</BusinessNameLine1>
          <BusinessNameLine2>Peter Rowe MD</BusinessNameLine2>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>200 N Wolfe St Room 2077</AddressLine1>
          <AddressLine2>David Rubenstein Child Health Bldg</AddressLine2>
          <City>Baltimore</City>
          <State>MD</State>
          <ZIPCode>21287</ZIPCode>
        </AddressUS>
        <EINOfRecipient>520595110</EINOfRecipient>
        <IRCSection>501(c)(3)</IRCSection>
        <AmountOfCashGrant>23579</AmountOfCashGrant>
        <AmountOfNonCashAssistance>0</AmountOfNonCashAssistance>
        <PurposeOfGrant>Peter Rowe, M.D., of Johns Hopkins Children's Center in Baltimore, Md., has observed that simple movements like a straight leg lift can trigger fatigue and brain fog in CFS patients. Dr. Rowe's group hypothesizes that the underlying mechanism is similar to fibromyalgia pain, where nerves become extra sensitive to stimulation, a process known as central sensitization. His work will be among the first to explore the possible link between fatigue, cognition and central sensitization. The results are expected to identify a subset of patients who will benefit from a different therapeutic approach.</PurposeOfGrant>
      </RecipientTable>
      <TotalNbrOf501C3AndGovtGrants>3</TotalNbrOf501C3AndGovtGrants>
      <TotalNbrOfOtherOrganizations>1</TotalNbrOfOtherOrganizations>
      <Form990ScheduleIPartIV>
        <Identifier>SchI_P01_S00_L02</Identifier>
        <ReturnReference>Schedule I, Part I, Line 2</ReturnReference>
        <Explanation>Schedule I, Part I, Line 2 - The Association awards grants for medical research projects in the field of CFS. To ensure that the most worthy and promising research projects are funded, the Association periodically engages volunteer peer reviewers with direct experience in the disciplines and fields specific to each funding application. Their reviews for scientific and strategic merit are weighed heavily by the Executive Committee of the Board of Directors when making final funding decisions. Applicants and their sponsoring organizations must agree and adhere to the Policies Governing the Award of Research Grants when completing the application form. Grantees approved for funding are required to submit written quarterly reports of the study's progress to the Association's Scientific Director according to the schedule outlined in the final letter of award. Grantee organizations are also required to submit two interim financial reports - at 7-month and 12-month intervals - to the Association's Chief Financial Officer. Failure to submit required reports by stated deadlines will result in suspension of future quarterly grant disbursements until all outstanding reports are received. Repeated or prolonged delinquency in reporting may result in suspension or withdrawal of support. The Association's Scientific Director may request a site visit or conference call to discuss information contained in interim progress reports and general progress toward stated project milestones. A Scientific Advisory Board comprised of researchers, physicians and regulatory experts provides guidance on the Association's research strategy to the staff and Board of Directors. It convenes periodically throughout the year.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="R000007" softwareId="12000197" softwareVersion="v1.00">
      <CompensationCommittee>X</CompensationCommittee>
      <WrittenEmploymentContract>X</WrittenEmploymentContract>
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>K Kimberly McCleary</NamePerson>
        <Title>President &amp; CEO</Title>
        <BaseCompensationFilingOrg>160477</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>6128</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>1000</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>167605</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartIII>
        <Identifier>SchJ_P01_S00_L03</Identifier>
        <ReturnReference>Schedule J, Part I, Line 3</ReturnReference>
        <Explanation>Schedule J, Part 1, Line 3 - Employees of the Association undergo periodic performance and compensation reviews. Compensation level is determined upon performance, market and the financial position of the Association. Historically, compensation increases follow a 4-6% trend. The President &amp; CEO and the Chief Financial Officer perform all reviews, except for that held for the President &amp; CEO which is done by members of the Professional Staff Recruiting and Compensation Committee (PSRCC). This committee is composed of all members of the Executive Committee of the Board and will consult with salary surveys published by reputable groups, including but not limited to GuideStar and the National Center for Non Profits, to ensure salary compensation is comparable to similar organizations for the President &amp; CEO. Compensation levels are approved by the PSRCC with minutes recorded and maintained for all meetings. All reviews include a written document which is discussed in person with the employee. Employees also provide a self-assessment as well as an evaluation of their immediate supervisor. Written reviews and self-assessments are kept in each employee's personnel file in a locked cabinet in the Chief Financial Officer's office.</Explanation>
      </Form990ScheduleJPartIII>
    </IRS990ScheduleJ>
    <IRS990ScheduleM documentId="R000008" softwareId="12000197" softwareVersion="v1.00">
      <SecuritiesPubliclyTraded>
        <NonCashCheckbox>X</NonCashCheckbox>
        <NumberOfContributions>6</NumberOfContributions>
        <NoncashContribsRptdF990>70437</NoncashContribsRptdF990>
        <MethodOfDeterminingRevenues>FMV</MethodOfDeterminingRevenues>
      </SecuritiesPubliclyTraded>
      <NumberOf8283Received>0</NumberOf8283Received>
      <AnyPropertyThatMustBeHeld>0</AnyPropertyThatMustBeHeld>
      <ReviewProcessUnusualNCGifts>0</ReviewProcessUnusualNCGifts>
      <ThirdPartiesUsed>0</ThirdPartiesUsed>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="R000009" softwareId="12000197" softwareVersion="v1.00">
      <GeneralExplanation>
        <Identifier>F990_P06_S0B_L11b</Identifier>
        <ReturnReference>Form 990, Part VI, Section B, Line 11b</ReturnReference>
        <Explanation>The Financial Oversight Committee (FOC) is responsible for reviewing the Association's tax return and providing comments prior to it being submitted to the IRS. The FOC consists of the Chairman of the Board, Vice-Chairman of the Board, Treasurer of the Board, President &amp; CEO and the Chief Financial Officer. All members of the Board of Directors receive a copy of the reviewed tax return prior to it being submitted to the IRS but are not required to provide comments.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>F990_P06_S0B_L12c</Identifier>
        <ReturnReference>Form 990, Part VI, Section B, Line 12c</ReturnReference>
        <Explanation>Each Director, Officer and committee members with governing board delegated powers annually sign a statement which affirms such person has: received a copy of the Conflict of Interest policy; read and understands the policy; agreed to comply with the policy; and understands the Association is a charitable organization and in order to maintain its federal tax exempt status must engage primarily in activities which accomplish one or more of its tax-exempt purposes.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>F990_P06_S0B_L15</Identifier>
        <ReturnReference>Form 990, Part VI, Section B, Line 15</ReturnReference>
        <Explanation>Employees of the Association undergo periodic performance and compensation reviews. Compensation level is determined upon performance, market and the financial position of the Association. Historically, compensation increases follow a 4-6% trend. The President &amp; CEO and the Chief Financial Officer perform all reviews, except for that held for the President &amp; CEO which is done by members of the Professional Staff Recruiting and Compensation Committee (PSRCC). This committee is composed of all members of the Executive Committee of the Board and will consult with salary surveys published by reputable groups, including but not limited to GuideStar and the National Center for Non Profits, to ensure salary compensation is comparable to similar organizations for the President &amp; CEO. Compensation levels are approved by the PSRCC with minutes recorded and maintained for all meetings. All reviews include a written document which is discussed in person with the employee. Employees also provide a self-assessment as well as an evaluation of their immediate supervisor. Written reviews and self-assessments are kept in each employee's personnel file in a locked cabinet in the Chief Financial Officer's office.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>F990_P06_S0C_L19</Identifier>
        <ReturnReference>Form 990, Part VI, Section C, Line 19</ReturnReference>
        <Explanation>The Association's tax return and Annual Report are available on its website. These reports are also available on Guidestar's webiste for visitors to that organization. Upon request, the Association will make available copies of its audited Financial Statements, Form 1023, governing By-Laws and Conflict of Interest Policy.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
  </ReturnData>
</Return>